Search PubMed⌕ Search

Biomedical subjects

Thomas F Warner

Publications and source records attributed to Thomas F Warner.

21 records · Page 2Linked to original sources

Testing a device to replace the leech for treating venous congestion.

OBJECTIVE: To test the effectiveness of a device designed to promote decongestion and tissue survival of a fasciocutaneous flap during 15 hours of complete venous obstruction. METHODS: In a porcine model, a 9 x 7-cm fasciocutaneous flap was elevated and the associated veins were clamped, causing complete venous obstruction for 15 hours in 6 control and 6 treatment animals. Up to 3 devices were used to treat the flap in a predetermined pattern. Control flaps were not treated. Measures of treatment efficacy included blood volumes removed; changes in skin color, surface perfusion, and tissue oxygen tension; and end point histologic findings. RESULTS: Control flaps were characterized by progressive darkening of skin color, undetectable surface perfusion, and low levels of oxygen tension. Histologic assessment showed severe congestion and extravasation of blood and distinct signs of necrosis. In contrast, treated flaps had significant improvements in skin color, surface perfusion, and subcutaneous oxygen tension. Histologic analysis showed little, if any, congestion and no signs of necrosis. Mean blood volume removed was 29.5 mL/h. CONCLUSION: The device was effective in decongesting a large area of tissue during 15 hours of complete outflow obstruction, based on quantitative measurements of tissue health and viability.

Animals↗

Beta-galactosidase-tagged adventitial myofibroblasts tracked to the neointima in healing rat vein grafts.

OBJECTIVE: Myofibroblasts are present transiently in normal healing wounds. However, they have been found to persist in the stroma of neoplasms, fibrotic conditions and other pathological settings. In rat vein grafts, we have observed the prolonged presence of myofibroblasts. Our aim was to determine the origin of myofibroblasts in vein grafts. METHODS: Epigastric vein to femoral artery grafts were microsurgically placed in male Lewis rats and harvested. Neointimal development, cellular death and proliferation, and cell phenotypes were analyzed using immunohistochemistry and light and electron microscopy. To follow cellular movement in the vessel wall, vein grafts were transfected with replication-defective adenovirus containing the gene encoding beta-galactosidase (n = 50), and harvested at 1, 2, 3, 4, 5, 6, 7, 14 and 28 days. Grafts were analyzed after X-gal staining. RESULTS: Myofibroblasts were detected in the outer adventitia at 4 days, in the media at 1 week and in the developing neointima at 2 weeks. Cells tagged using adenoviral beta-galactosidase demonstrated adventitia to neointima cell migration. CONCLUSIONS: Although there may be other sources of myofibroblasts in this model, the adventitia has been shown to be an origin of myofibroblasts which subsequently migrate through the vessel wall to the neointima during graft remodeling and contribute to neointimal formation.

Adenoviridae↗